Publications

Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.

Cavanagh, DR; Dodoo, D; Hviid, L; Kurtzhals, JA L; Theander, TG; Akanmori, BD; Polley, S; CONWAY, DJ; Koram, K; McBride, JS;

2004

INFECTION AND IMMUNITY, (2004).72 11 10.1128/IAI.72.11.6492-6502.2004.

Factors influencing the uptake of childhood immunisation in rural areas.

Henderson, R; Oates, K; MacDonald, H; Smith, WC S; Selvaraj, S;

2004

The British journal of general practice, (2004).54 499

Genetically engineered structure-based vaccine for bluetongue disease.

ROY, P;

2004

Veterinaria italiana, (2004).40 4

Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy.

Obaro, SK; Deubzer, HE; Newman, VO; Adegbola, RA; GREENWOOD, BM; Henderson, DC;

2004

The Pediatric infectious disease journal, (2004).23 11 10.1097/01.inf.0000143651.54880.09.

Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.

Pinder, M; Reece, WH H; Plebanski, M; Akinwunmi, P; Flanagan, KL; Lee, EA M; Doherty, T; MILLIGAN, P; Jaye, A; Tornieporth, N; Ballou, R; McAdam, KP M J; Cohen, J; Hill, AV S;

2004

Clinical and experimental immunology, (2004).135 2 10.1111/j.1365-2249.2004.02371.x.

Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia.

SCOTT, S; Mossong, J; Moss, WJ; Cutts, FT; Kasolo, F; Sinkala, M; COUSENS, S;

2004

Vaccine, (2004).23 6 10.1016/j.vaccine.2004.07.026.

Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.

Cavanagh, DR; Dodoo, D; Hviid, L; Kurtzhals, JA L; Theander, TG; Akanmori, BD; POLLEY, S; CONWAY, DJ; Koram, K; McBride, JS;

2004

Infection and immunity, (2004).72 11 10.1128/IAI.72.11.6492-6502.2004.

Polio control after certification: major issues outstanding.

FINE, PE M; Oblapenko, G; Sutter, RW;

2004

Bulletin of the World Health Organization, (2004).82 1

Risk of myocardial infarction and stroke after acute infection or vaccination.

SMEETH, L; THOMAS, SL; Hall, AJ; Hubbard, R; Farrington, P; Vallance, P;

2004

The New England journal of medicine, (2004).351 25 10.1056/NEJMoa041747.

Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.

Van Dyck, E; Buvé, A; WEISS, HA; GLYNN, JR; Brown, DW G; De Deken, B; Parry, J; HAYES, RJ;

2004

Journal of clinical microbiology, (2004).42 7 10.1128/JCM.42.7.2961-2965.2004.